Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function
Open Access
- 1 December 2006
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 55 (12), 3463-3469
- https://doi.org/10.2337/db06-0307
Abstract
In previous studies, glucagon receptor knockout mice (Gcgr−/−) display reduced blood glucose and increased glucose tolerance, with hyperglucagonemia and increased levels of glucagon-like peptide (GLP)-1. However, the role of glucagon receptor signaling for the regulation of islet function and insulin sensitivity is unknown. We therefore explored β-cell function and insulin sensitivity in Gcgr−/− and wild-type mice. The steady-state glucose infusion rate during hyperinsulinemic-euglycemic clamp was elevated in Gcgr−/− mice, indicating enhanced insulin sensitivity. Furthermore, the acute insulin response (AIR) to intravenous glucose was higher in Gcgr−/− mice. The augmented AIR to glucose was blunted by the GLP-1 receptor antagonist, exendin-3. In contrast, AIR to intravenous administration of other secretagogues was either not affected (carbachol) or significantly reduced (arginine, cholecystokinin octapeptide) in Gcgr−/− mice. In islets isolated from Gcgr−/− mice, the insulin responses to glucose and several insulin secretagogues were all significantly blunted compared with wild-type mice. Furthermore, glucose oxidation was reduced in islets from Gcgr−/− mice. In conclusion, the present study shows that glucagon signaling is required for normal β-cell function and that insulin action is improved when disrupting the signal. In vivo, augmented GLP-1 levels compensate for the impaired β-cell function in Gcgr−/− mice.Keywords
This publication has 26 references indexed in Scilit:
- Neuropeptides and the Regulation of Islet FunctionDiabetes, 2006
- Both fasting glucose production and disappearance are abnormal in people with “mild” and “severe” type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic miceMetabolism, 2002
- Lack of Suppression of Glucagon Contributes to Postprandial Hyperglycemia in Subjects with Type 2 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2000
- Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian womenDiabetologia, 2000
- Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic ratsDiabetologia, 1994
- Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic functionDiabetes, 1993
- Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clampMetabolism, 1991
- Obesity and insulin resistance in humans: A dose-response studyMetabolism, 1990
- Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.JCI Insight, 1981